Finally, we observed similar changes in BCL2, BAX, BNIP3, and NLRP3 in both AKI groups, suggesting that treatment has not yet attenuated proapoptotic and inflammatory signaling as seen in the 10-day cohort (Figure 8, F–J). The gene discussed is BCL2; the disease is acute kidney injury.